Argentina Antirheumatic Drugs market was valued at US$879.042 million in 2019. The rising predominance of malaria cases in Argentina because of climatic conditions is a factor that is fuelling the market development of antirheumatic drugs in the nation. The high predominance of the residential pharmaceutical industry is additionally contributing altogether to argentina antirheumatic drugs market as the locally produced drugs are route less expensive than the imported ones.